Thought about that as well.
I think anything below $.20 makes no sense for long term shareholders at all.
The last updates talking delay in customer payments and sending people home underlines the difficulties but I still think the purchase would be strategic with Revasum in a pool of only a handful suppliers and therefore should be higher than just the market cap.
Wheeler once said most fabs get a mix of machines from different suppliers.
- Forums
- ASX - By Stock
- RVS
- Ann: Update on Strategic Process and Financing
Ann: Update on Strategic Process and Financing, page-7
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)